ETFsNASDAQ Next Generation 100 Index
Invesco
Invesco NASDAQ Next Generation 100 UCITS ETF Acc
EQQJ XETRAIrelandNot PEA-eligible
Last close · EUR
46.91EUR
-2.53% · -€1.22
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
EQQJBase
- Fund charges
- 0.25%PRIIPs ongoing costs
- Fund size
- €43.9Mall share classes
- Return 1Y
- +21.9%
- Sharpe 3Y
- 1.06
- Volatility 1Y
- 16.4%annualised
- Holdings
- 104Fund holdings
Performance
Compare
- EQQJ+21.9%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| EQQJ | -3.9% | -1.8% | +9.8% | +21.5% | +21.9% | +75.7% | +29.7% |
| MSCI World | -2.8% | -0.6% | +7.8% | +14.0% | +14.1% | +65.6% | +64.8% |
| Gap to MSCI World | -1.1% | -1.2% | +1.9% | +7.5% | +7.8% | +10.1% | -35.1% |
Risk and return
Sharpe ratio · 3Y
1.06
Below MSCI World · 1.24- Return p.a.
- +21.7%
- Volatility
- 17.3%
- Max loss
- -27.7%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
EQQJ
1.06
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 20.5%
- Holdings
- 104
- As of
- 1NATERA INC USD0.0001US63230710422.82%
- 2EBAY INC USD0.001US27864210302.78%
- 3REVOLUTION MEDICINES INC USD NPVUS76155X10002.14%
- 4Biogen Inc USD0.0005US09062X10371.88%
- 5UNITED AIRLINES HOLDINGS INC USD0.01US91004710961.88%
- 6NETAPP INC USD0.001US64110D10461.84%
- 7Expedia Group Inc USD0.001US30212P30381.81%
- 8KIMBERLY-CLARK CORP USD1.25US49436810351.81%
- 9MEDLINE INC-CL A USD 0.0001US58507V10701.77%
- 10STEEL DYNAMICS INC USD0.005US85811910091.72%
Countries
Not published · Country classification unavailable
Market cap
Weight vs holdings
20.5%of the fund sits in the top 10 holdings
20.5%48.6%30.9%
WeightHoldings
104054
- Holdings 1-10
- Holdings 11-50
- Holdings 51-104
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
